Closed
1.27 6.72
24h
Min
1.17
Max
1.32
Income | -89M -97M |
---|---|
Sales | 4.9M 9.2M |
EPS | -1.01 |
Profit margin | -1,048.225 |
Employees | 61 |
EBITDA | -4.4M -14M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +677.31% upside |
Next Earnings | 6 maj 2025 |
---|
Market Cap | -86M 123M |
---|---|
Previous open | -5.45 |
Previous close | 1.27 |
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 9.25 USD 677.31%
High 15 USD
Low 2 USD
Based on 5 Wall Street analysts offering 12 month price targets forAclaris Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$